Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

http://www.wikidata.org/entity/Q36571755

about

Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier Nanocarrier-based therapies for CNS tumors.Nanomaterials and neurodegeneration.Nanotherapeutic strategies for the treatment of Alzheimer's disease.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.Titanium dioxide food additive (E171) induces ROS formation and genotoxicity: contribution of micro and nano-sized fractions.Nanomedicine applications in women's health: state of the art.Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities

P2860

Q26783306-6B2FCFEC-5F0E-408B-A6FB-5AB5FECD3C16 Q28071873-5C23453A-F9AE-421F-BFB7-953FEF2FC54F Q38233169-9F38A9F3-601B-409E-9AAE-B58405AB0884 Q38334868-4E82FE31-2E09-4B8C-AA81-0D47065A7FE3 Q38358865-DF29E2A3-6576-45AE-A01D-F72FB7E2D3BB Q38686370-8845AE65-16CB-4F26-8A88-E44EB21C11D8 Q38808008-836E52BE-0CC7-4A15-B9B1-F0E6CD226085 Q46467747-6EDA55E7-4C2C-4B8D-BEDA-319F5BF0FBC7 Q55091399-49BFC6B3-FA42-4E78-AB55-D45764BAE4E0 Q58571824-9B127BBC-229B-4C78-AFF4-D031897F1E0C

P2860

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

http://www.wikidata.org/entity/Q36571755

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Potential therapeutic effect o ...... model of Alzheimer's disease.

@ast

Potential therapeutic effect o ...... model of Alzheimer's disease.

@en

type

label

Potential therapeutic effect o ...... model of Alzheimer's disease.

@ast

Potential therapeutic effect o ...... model of Alzheimer's disease.

@en

prefLabel

Potential therapeutic effect o ...... model of Alzheimer's disease.

@ast

Potential therapeutic effect o ...... model of Alzheimer's disease.

@en

P1433

Q36571755-1F7E825F-3B72-4390-9440-5CE854DEC38B

P1476

Q36571755-36B6BB95-90CD-46D1-B96A-4271044D84BB

P2093

Q36571755-63D6862B-EBB3-4ABB-ACAE-D9F98BD50268

P2860

Q36571755-05355B88-D4DF-442E-BF8E-435C372DDCED

Q36571755-07F2F55D-C5B7-4D42-A8BB-153C4AC42EC8

Q36571755-1852CA8D-A923-48DA-BC6C-D05594D79770

Q36571755-238B2397-BEB1-41FF-8514-DDF297E09EEA

Q36571755-2536FA2A-A4DE-40C6-AF5B-6BDDE6A58E63

Q36571755-27F36A6C-45A0-4486-A737-0CC667DE3F0C

Q36571755-2DEA5079-C559-45ED-9E27-875D53CCDE89

Q36571755-2E2E0E91-09B1-4C60-B0DF-923851412524

Q36571755-2E93E037-FD3B-4E4D-8668-A113C8ECF4D4

Q36571755-304553B7-31FB-4BE0-944E-6DD7F4018500

P304

Q36571755-9A5172C1-8593-4A05-B2AC-0CDA94998CB2

P31

Q36571755-4554530E-5CF9-4CDF-84D9-BE4BA3897B2B

P356

Q36571755-FF4DD6C2-B211-441F-85D2-73C4FD73D3CA

P407

Q36571755-79A9B14C-5802-4000-BB16-44ADDD7841CB

P478

Q36571755-08A390E9-800D-4B36-8054-B836222BEA48

P50

Q36571755-A3F6FBC7-0769-401F-B475-2777808E1594

Q36571755-E0AE4F5F-D000-412F-9C9D-F4B3CE53D30D

P577

Q36571755-850095F9-D653-4DAD-ACBE-3E2CF5662003

P698

Q36571755-54E92198-264F-48A4-98F7-E3C593617B2A

P921

Q36571755-25DCA0CA-4BD5-4F05-A28E-3D2B6329A795

P932

Q36571755-90E6C38B-141B-459E-9D30-E4A841B39294

P356

P1433

International Journal of Nanomedicine

P1476

Potential therapeutic effect o ...... t model of Alzheimer's disease

@en

P2093

Manal Fouad Ismail

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.

Inflammation and Alzheimer's disease

Alzheimer disease: progress or profit?

Cholinotoxic effects of aluminum in rat brain

Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons

Recent advances with liposomes as pharmaceutical carriers

Alzheimer's disease

Developments of a water-maze procedure for studying spatial learning in the rat

P304

393-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S39232

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Aliaa Nabil ElMeshad

Neveen A. Salem

P577

2013-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23378761

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3558309

http://www.w3.org/2001/XMLSchema#string